logo1
Resources and Advisory Services

Wise and practical investors concern themselves with only these corp gov improvements: 

  • Restrict poison pills
  • Declassify BoDs
  • Separate CEO and BoD chair position
  • Allow proxy access. 

Earlier, we urged investors to think about poison pills, declassified BoDs, and proxy access. After the sad spectacle at Allergan, we added the CEO-BoD chair priority. Proxy access becomes the "one-half" item because the difficulty of gaining any sort of access makes it less urgent, though no less important. 

 

So, how did these critical improvements fare in 2014? Pretty well, although we'd describe ourselves as happy but not satisfied. Our current blog post refers to the ever-useful Proxy Season Wrap-Up from Alliance Advisors for the data.

Recent TAI blog posts

You can find other useful resources at the TAI website, including our research on "Effective Activism, on the Cheap", our new resource guide on activist investing data sourcesour white paper with the basics on activist investing, and our new guides on exempt solicitationconsent solicitation, and special shareholder meetings. 
For further information, please contact:
 
Michael R. Levin
[email protected]
847.830.1479